期刊文献+

病毒核酸检测在献血者保留中的应用 被引量:5

The application of nucleic acid testing in keeping blood donor
下载PDF
导出
摘要 目的了解安阳地区献血人群中,乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)用酶联免疫吸附法(ELASL)检测的假阳性情况,对无偿献血人群的血标本进行HBV和HCV核酸检测(NAT)的可行性评估。方法对无偿献血者血液样本50 267份开展ELISA检测,对乙型肝炎病毒表面抗原(HBsAg)和抗丙型肝炎病毒抗体(抗-HCV)阳性标本开展实时荧光定量PCR检测,并对ELISA单试剂(+)NAT(-)献血者6个月后进行追踪检测。结果两个项目两种ELISA试剂检测结果不相符率达46.7%,ELISA检测方法单试剂阳性者PCR呈阴性者249份,ELISA检测方法双试剂阳性者PCR呈阴性者103份。HBV项目单试剂阳性组与双试剂阳性组比较,差异有统计学意义(χ2=114.154,P<0.01);HCV项目单试剂阳性组与双试剂阳性组比较,差异有统计学意义(χ2=61.109,P<0.01)。ELISA单试剂(+)NAT(-)献血者有91名被追踪检测成功,其中83人检测结果为ELISA(-)NAT(-)。结论 NAT可有效的检测出无偿献血人群中ELISA检测方法呈阳性的阴性标本,应考虑在该地区无偿献血人群中进行NAT,以便更好地保留献血者,提高固定献血者比例。 Objective To find out the situation of Hepatitis B virus and Hepatitis C virus in Anyang city by analyzing false positive on ELISA method,and to assess blood samples of voluntary blood donors using detecting nucleic acid of HBV and HCV.Methods ELISA makes blood samples of 50 267 voluntary blood donors,and Real Time PCR tests positive specimens on HBsAg and antibody to HCV,and then blood donors whose results were single positive ELISA and negative NAT would be tracked after 6 months.Results The unmatch rate between two ELISA products in HBV and HCV tests was 46.7%.There were 249 specimens which showed positive in either of two ELISA tests but negative in PCR,and 103 samples that perform positive data in both ELISA products but negative PCR results.The χ2 was 114.154(P&lt;0.01) between single and both positive HBV results,and this statistical item was 61.109(P&lt;0.01) in HCV comparison.83 of 91 tracked men had ELISA(-)NAT(-) results.Conclusion Real Time PCR could distinguish effectively false positive ELISA results of voluntary blood donors.We should apply Real Time PCR to our volunteers for keeping current blood donors and improving regular ones.
作者 李新建
出处 《国际检验医学杂志》 CAS 2013年第10期1230-1231,1233,共3页 International Journal of Laboratory Medicine
关键词 输血 核酸类 聚合酶链反应 blood transfusion nucleic acids polymerase chain reaction
  • 相关文献

参考文献12

二级参考文献42

共引文献235

同被引文献51

  • 1谢立,吴晓东.丙型肝炎病毒检测方法的研究进展及其临床意义[J].世界华人消化杂志,2005,13(7):884-886. 被引量:56
  • 2Masser BM, Bednall TC, White KM, et al. Predicting the retention of first-time donors using an extended theory of planned behavior. Transfusion,2012,52 (6) :1303-1312.
  • 3Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodefieiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleicacid testing. Transfusion ,2010,50 (7) : 1495-1504.
  • 4Zou S,Musavi F,Notari EP,et al. Donor deferral and resulting donor loss at the American Red Cross Blood Services,2001 through 2006. Transfusion,2008,48 (12) :2531-2539.
  • 5O'Brien SF, Yi QL, Fan W, et al. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang. 2012,103( 1 ) :83-86.
  • 6Cable R, Lelie N, Bird A. Reduction of the risk of transfusion-trans- mitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa:a 5-year review. Vox Sang, 2013 , 104(2) :93-99.
  • 7王远忠,邢少军,侯秀丽.6家ELISA丙型肝炎诊断试剂盒的比较[J].旅行医学科学,2007,13(4):45-47. 被引量:5
  • 8Choo QLfKuo G,Weiner AJ,et al.Isolation of a cDNA clone de- rived from a blood-borne non-A,non-B viral hepatitis genome[J].Seience,1989,244(2):359-362.
  • 9Sy T,Jama MM.Epidemiology of hepatitis C virus( HCV)infec- tion[J].Int J Med Scif 2006,3(1):41-46.
  • 10Lavanchy.The global burden of hepatitis C[J].Liver Int,2009,29(1):74-81.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部